GENE ONLINE|News &
Opinion
Blog

Lymphoma
Canada Authorizes Roche’s Polivy as First-Line Lymphoma Treatment
2022-11-27
CHMP Gives Kite’s Lymphoma Immunotherapy a Positive Opinion
2022-09-16
AbClon, HK inno.N Collaborates to Take On Novartis’ CAR T-Cell Therapy
2022-02-15
Angel Pharma Pushes First-In-Class ITK Inhibitor into Trial in China
2021-10-27
BeiGene Gets Its First Regulatory Nod in Australia for Rare Lymphoma
2021-10-08
Roche Aspires for Dominance in DLBCL Market, Unveils Pivotal Trial Data for Polivy
2021-08-09
TG Therapeutics Gets Conditional FDA Okay for its First Lymphoma Drug
2021-02-09
Taiwan Approves Six Cell Therapies Under Revised Guidelines
2018-09-13
LATEST
World Vaccine Congress Washington 2025 Recap: Urgent Calls for Trust, Tech, and Global Access
2025-04-25
Astellas’ Transformation Journey: From Merger to Global Player, Betting on the Edge of Innovation and Risk?
2025-04-25
Roche Announces Massive 50 Billion Dollar Investment in the United States
2025-04-25
Steminent Stands Ready to Showcase Novel MSC-based Therapy for Spinocerebellar Ataxia at Global Stage
2025-04-24
Arkansas Medicaid Work Requirements Led to Coverage Loss for a Significant Number of Recipients
2025-04-24
Boehringer agrees new partnership to advance first-in-class precision cancer therapies
2025-04-24
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics
2025-04-24
EVENT
2025-04-25
AACR Annual Meeting 2025
Chicago, U.S.A
2025-05-03
29th Taiwan Joint Cancer Conference 2025
Taipei, Taiwan
2025-05-05
Swiss Biotech Day 2025
Basel, Switzerland
2025-05-13
ASGCT 28th Annual Meeting 2025
New Orleans, U.S.A.
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
Scroll to Top